Burcon Price To Sales Ratio vs Interest Coverage Analysis
BU Stock | CAD 0.12 0.01 9.09% |
Burcon NutraScience financial indicator trend analysis is way more than just evaluating Burcon NutraScience prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Burcon NutraScience is a good investment. Please check the relationship between Burcon NutraScience Price To Sales Ratio and its Interest Coverage accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burcon NutraScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Price To Sales Ratio vs Interest Coverage
Price To Sales Ratio vs Interest Coverage Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Burcon NutraScience Price To Sales Ratio account and Interest Coverage. At this time, the significance of the direction appears to have no relationship.
The correlation between Burcon NutraScience's Price To Sales Ratio and Interest Coverage is 0.06. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Interest Coverage in the same time period over historical financial statements of Burcon NutraScience, assuming nothing else is changed. The correlation between historical values of Burcon NutraScience's Price To Sales Ratio and Interest Coverage is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Burcon NutraScience are associated (or correlated) with its Interest Coverage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Coverage has no effect on the direction of Price To Sales Ratio i.e., Burcon NutraScience's Price To Sales Ratio and Interest Coverage go up and down completely randomly.
Correlation Coefficient | 0.06 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Burcon NutraScience stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Burcon NutraScience sales, a figure that is much harder to manipulate than other Burcon NutraScience multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Interest Coverage
Most indicators from Burcon NutraScience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Burcon NutraScience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burcon NutraScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. As of the 2nd of December 2024, Selling General Administrative is likely to drop to about 3.3 M. Issuance Of Capital Stock is expected to grow at the current pace this year
Burcon NutraScience fundamental ratios Correlations
Click cells to compare fundamentals
Burcon NutraScience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Burcon NutraScience fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.3M | 37.7M | 29.3M | 9.9M | 12.9M | 10.9M | |
Other Current Liab | 249.3K | 28.5K | 522.0 | 34.7K | 250K | 234.8K | |
Total Current Liabilities | 1.6M | 1.4M | 1.0M | 625.4K | 1.4M | 859.2K | |
Total Stockholder Equity | 22.9M | 36.3M | 28.2M | 4.1M | 5.2M | 9.1M | |
Net Debt | (8.3M) | (13.9M) | (6.9M) | 3.7M | 2.5M | 2.6M | |
Retained Earnings | (98.4M) | (99.0M) | (109.2M) | (134.6M) | (142.0M) | (134.9M) | |
Cash | 15.0M | 14.0M | 7.0M | 1.5M | 4.2M | 4.8M | |
Non Current Assets Total | 15.5M | 23.1M | 21.7M | 8.0M | 7.7M | 5.4M | |
Non Currrent Assets Other | (13.9M) | (18.7M) | (15.5M) | 5.4M | 4.8M | 5.1M | |
Cash And Short Term Investments | 15.0M | 14.0M | 7.0M | 1.5M | 4.2M | 5.2M | |
Net Receivables | 332.2K | 338.7K | 200.3K | 332.1K | 134.6K | 111.3K | |
Common Stock Shares Outstanding | 78.9M | 102.9M | 108.6M | 108.7M | 121.4M | 127.5M | |
Liabilities And Stockholders Equity | 31.3M | 37.7M | 29.3M | 9.9M | 12.9M | 10.9M | |
Other Current Assets | 289.3K | 154.8K | 414.3K | 75.9K | 787.2K | 826.5K | |
Total Liab | 8.3M | 1.5M | 1.1M | 5.8M | 7.8M | 8.1M | |
Total Current Assets | 15.8M | 14.6M | 7.6M | 1.9M | 5.2M | 5.6M | |
Property Plant And Equipment Net | 470.5K | 1.0M | 859.4K | 983.9K | 1.1M | 647.2K | |
Accounts Payable | 1.1M | 1.4M | 906.1K | 590.9K | 843.4K | 573.6K | |
Other Stockholder Equity | 9.0M | 21.1M | 15.9M | 16.8M | 17.3M | 17.5M | |
Property Plant And Equipment Gross | 470.5K | 4.9M | 5.1M | 5.4M | 6.2M | 6.5M | |
Accumulated Other Comprehensive Income | (3.6M) | (3.9M) | 12.1K | 7.4M | 7.8M | 8.2M | |
Short Term Debt | (275.6K) | 28.4K | 13.9K | 34.4K | 260.8K | 247.8K | |
Current Deferred Revenue | 275.6K | (28.5K) | 122.7K | (34.7K) | (31.2K) | (29.7K) | |
Non Current Liabilities Total | 6.7M | 5.3K | 58.7K | 5.1M | 6.4M | 6.7M | |
Inventory | 132.1K | 132.5K | 0.0 | 68.3K | 78.6K | 61.0K | |
Net Tangible Assets | 21.7M | 35.0M | 27.0M | 2.9M | 3.3M | 3.1M | |
Property Plant Equipment | 470.5K | 1.0M | 859.4K | 983.9K | 1.1M | 684.2K | |
Capital Surpluse | 9.0M | 14.1M | 15.9M | 16.9M | 19.4M | 11.8M | |
Short Long Term Debt Total | 6.7M | 33.7K | 73.1K | 5.2M | 6.7M | 4.0M | |
Long Term Debt | 1.9M | 0.0 | 6.7M | 5.1M | 5.9M | 6.2M | |
Long Term Debt Total | 6.7M | 5.3K | 58.7K | 5.1M | 5.9M | 6.2M | |
Cash And Equivalents | 15.0M | 14.0M | 7.0M | 1.5M | 1.7M | 1.6M |
Other Information on Investing in Burcon Stock
Balance Sheet is a snapshot of the financial position of Burcon NutraScience at a specified time, usually calculated after every quarter, six months, or one year. Burcon NutraScience Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Burcon NutraScience and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Burcon currently owns. An asset can also be divided into two categories, current and non-current.